SEC Comment Letter 0000000000-24-009024 to Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc.
Date: Aug. 7, 2024 · CIK: 0001411690 · Accession: 0000000000-24-009024
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281138
Letter
August 7, 2024 R. Erik Holmlin, Ph.D. President and Chief Executive Officer Bionano Genomics, Inc. 9540 Towne Centre Drive, Suite 100 San Diego, CA 92121 Re:Bionano Genomics, Inc. Registration Statement on Form S-3 Filed July 31, 2024 File No. 333-281138 Dear R. Erik Holmlin Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at 202-551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
August 7, 2024
R. Erik Holmlin, Ph.D.
President and Chief Executive Officer
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, CA 92121
Re:Bionano Genomics, Inc.
Registration Statement on Form S-3
Filed July 31, 2024
File No. 333-281138
Dear R. Erik Holmlin Ph.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Abby Adams at 202-551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services